Skip to main content

Table 3 Results of differential gene expression analysis in brain

From: Genome-wide pleiotropy analysis of neuropathological traits related to Alzheimer’s disease

 

RNA-Seq

Microarray

CER

TCX

CER

DLPFC

VCX

Gene

β value (SE)

P value

β value (SE)

P value

β value (SE)

P value

β value (SE)

P value

β value (SE)

P value

ECRG4 a

0.06 (0.20)

0.77

0.19 (0.24)

0.43

−0.18 (0.05)

1.6 × 10 −3

−0.12 (0.06)

0.04

−0.12 (0.04)

2.7 × 10−3

HDAC9

−0.24 (0.12)

0.04

−0.31 (0.08)

1.5 × 10 −4

−0.01 (0.02)

0.77

−0.09 (0.03)

7.9 × 10−3

−0.06 (0.02)

5.6 × 10 −4

TRAPPC12

−0.05 (0.06)

0.35

−0.13 (0.05)

0.01

−0.09 (0.03)

1.1 × 10 −3

−0.03 (0.02)

0.09

−0.08 (0.02)

3.2 × 10 −4

TRAPPC12-AS1

0.22 (0.12)

0.06

0.59 (0.18)

1.3 × 10 −3

ADI1

−0.10 (0.08)

0.19

−0.07 (0.08)

0.36

−0.10 (0.03)

4.9 × 10 −4

−0.03 (0.03)

0.31

−0.01 (0.03)

0.64

  1. Abbreviations: CER Cerebellum, TCX Temporal cortex, DLPFC Dorsolateral prefrontal cortex, CER Cerebellum, TCX Temporal cortex, DLPFC Dorsolateral prefrontal cortex, VCX Visual cortex
  2. Results were obtained from analyses of RNA-Seq data in the Synapse database (https://www.synapse.org; [17]) and microarray data in the Gene Expression Omnibus database [GEO:GSE44771]. Negative β value indicates lower level of gene expression in AD cases compared with controls and vice versa. Results that remained significant after multiple test correction (P = 0.05/22 = 2.27 × 10−3) are highlighted in bold
  3. aAlso known as C2orf40